Gateway Investment Advisers LLC Ionis Pharmaceuticals Inc Transaction History

Gateway Investment Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$37.12 - $46.52 $36,192 - $45,357	975 Added 1.94%	51,174 $0
Q3 2022 Oct 07, 2022	SELL	$36.54 - $48.66 $1.79 Million - $2.38 Million	-48,930 Reduced 49.36%	50,199 $2.22 Million
Q1 2022 Apr 14, 2022	BUY	$29.88 - $37.04 $419,096 - $519,523	14,026 Added 16.48%	99,129 $3.67 Million
Q4 2021 Jan 14, 2022	BUY	$25.61 - $35.1 $1.2 Million - $1.65 Million	46,971 Added 123.18%	85,103 $2.59 Million
Q3 2021 Oct 22, 2021	BUY	$33.54 - $40.55 $17,843 - $21,572	532 Added 1.41%	38,132 $1.28 Million
Q2 2020 Jul 15, 2020	SELL	$46.85 - $61.05 $1.82 Million - $2.37 Million	-38,876 Reduced 50.83%	37,600 $2.22 Million
Q1 2020 Apr 13, 2020	BUY	$41.6 - $63.4 $1.56 Million - $2.38 Million	37,513 Added 96.28%	76,476 $3.62 Million
Q4 2019 Jan 09, 2020	SELL	$53.85 - $65.27 $176,789 - $214,281	-3,283 Reduced 7.77%	38,963 $2.35 Million
Q3 2019 Oct 15, 2019	BUY	$59.06 - $72.15 $47,425 - $57,936	803 Added 1.94%	42,246 $2.53 Million
Q2 2019 Jul 17, 2019	BUY	$62.09 - $86.14 $2.57 Million - $3.57 Million	41,443 New	41,443 $2.66 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Investment Advisers LLC with notifications on news.